The company said that net income attributable to common stockholders for Q1 2025 was $766 million, or $0.77 per diluted share, and adjusted income attributable to common stockholders (non-GAAP) was $860 million, or $0.87 per diluted share.

1. 01

   The company said that net income attributable to common stockholders for Q1 2025 was $766 million, or $0.77 per diluted share, and adjusted income attributable to common stockholders (non-GAAP) was $860 million, or $0.87 per diluted share.

2. 02

   Occidental said operating cash flow was $2.1 billion and operating cash flow before working capital was $3.0 billion for Q1 2025. It said free cash flow before working capital, after capital expenditures of $1.9 billion and contributions from noncontrolling interest of $63 million, was $1.2 billion.

3. 03

   The company said it closed asset sales of $1.3 billion in Q1 2025 and had repaid $2.3 billion of debt to date in 2025.

4. 04

   Occidental said oil and gas pre-tax income was $1.7 billion and OxyChem pre-tax income was $185 million for Q1 2025. It also said it reduced the mid-point of its 2025 capital spending guidance by $200 million and cut domestic operating costs by $150 million.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the opening part of the filing body and confirmed exhibits, within a length limit. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.